Articles published by Verastem Oncology
Verastem Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
June 15, 2023
From Verastem Oncology
Via Business Wire
Tickers
VSTM
Verastem Oncology Announces Reverse Stock Split
May 31, 2023
From Verastem Oncology
Via Business Wire
Tickers
VSTM
New Verastem Oncology Initiative, Let’s Talk About LGSOC, Calls Attention to Rare Form of Ovarian Cancer
March 15, 2023
From Verastem Oncology
Via Business Wire
Tickers
VSTM
Verastem Oncology Announces Up to $60 Million Private Placement Offering of Series B Convertible Preferred Stock
January 24, 2023
From Verastem Oncology
Via Business Wire
Tickers
VSTM
Verastem Oncology Appoints Rob Gagnon to Board of Directors
December 15, 2022
From Verastem Oncology
Via Business Wire
Tickers
VSTM
Verastem Oncology Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
November 03, 2022
From Verastem Oncology
Via Business Wire
Tickers
VSTM
Verastem Oncology Appoints Anil Kapur to Board of Directors
October 20, 2022
From Verastem Oncology
Via Business Wire
Tickers
VSTM
Verastem Oncology Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
August 08, 2022
From Verastem Oncology
Via Business Wire
Tickers
VSTM
Verastem Oncology Names Preeminent Oncology Researcher Channing Der, PhD, to its Scientific Advisory Board
March 24, 2022
From Verastem Oncology
Via Business Wire
Tickers
VSTM
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.